From: Design, synthesis and antimicrobial evaluation of pyrimidin-2-ol/thiol/amine analogues
Compounds no. | Minimum inhibitory concentration (MIC = µM/ml) | ||||||
---|---|---|---|---|---|---|---|
Bacterial strains | Fungal strains | ||||||
Gram positive | Gram negative | ||||||
S. aureus (MTCC 3160) | B. subtilis (MTCC 441) | E. coli (MTCC 443) | P. aeruginosae (MTCC 3542) | S. enteric (MTCC 1165) | C. albicans (MTCC 227) | A. Niger (MTCC 281) | |
1. | 1.91 | 3.83 | 1.91 | 1.91 | 1.91 | 3.83 | 3.83 |
2. | 1.82 | 3.64 | 0.91 | 1.82 | 1.82 | 1.82 | 3.64 |
3. | 1.91 | 3.83 | 0.96 | 1.91 | 3.83 | 3.83 | 3.83 |
4. | 3.64 | 3.64 | 1.82 | 0.91 | 3.64 | 3.64 | 3.64 |
5. | 1.91 | 0.96 | 1.91 | 1.91 | 3.83 | 1.91 | 3.83 |
6. | 1.82 | 3.64 | 1.82 | 1.82 | 3.64 | 1.82 | 3.64 |
7. | 3.81 | 3.81 | 1.91 | 1.91 | 3.81 | 1.91 | 3.81 |
8. | 3.88 | 3.88 | 1.94 | 3.88 | 3.88 | 1.94 | 3.88 |
9. | 1.94 | 3.88 | 1.94 | 3.88 | 3.88 | 3.88 | 3.88 |
10. | 3.09 | 1.55 | 1.55 | 0.77 | 1.55 | 3.09 | 3.09 |
11. | 1.68 | 3.37 | 1.68 | 3.37 | 3.37 | 3.37 | 1.68 |
12. | 0.87 | 1.73 | 1.73 | 1.73 | 1.73 | 1.73 | 3.46 |
13. | 0.93 | 3.72 | 1.86 | 3.72 | 3.72 | 1.86 | 3.72 |
DMSO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cefadroxil | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | – | – |
Fluconazole | – | – | – | – | – | 2.04 | 2.04 |